{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T09:32:52Z","timestamp":1793871172562,"version":"4.6.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Atrial fibrillation and acute heart failure frequently co-exist and can exacerbate each other. Their combination leads to increased morbidity and mortality. However, the prevalence and significance, as well as the treatment, of atrial fibrillation in acute heart failure are not well studied. Management of atrial fibrillation in acute heart failure requires a multidisciplinary team approach. Treatment of underlying disease(s), identification and treatment of potentially correctable causes and precipitating factors and anticoagulation are crucial. In this article, current evidence on atrial fibrillation in the setting of acute heart failure is summarised. The recommendations on management of atrial fibrillation in the prehospital stage, the treatment of reversible causes, when and how to use rate or rhythm control, maintenance of sinus rhythm, catheter ablation and pacing, anticoagulation, as well as measures on prevention of atrial fibrillation are provided.<\/jats:p>","DOI":"10.1177\/2048872619894255","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T09:42:18Z","timestamp":1579858938000},"page":"348-357","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":41,"title":["Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology"],"prefix":"10.1093","volume":"9","author":[{"given":"Bulent","family":"Gorenek (Chair)","sequence":"first","affiliation":[{"name":"Cardiology Department , Eskisehir Osmangazi University, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrun","family":"Halvorsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology , Oslo University Hospital Ulleval, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulmira","family":"Kudaiberdieva","sequence":"additional","affiliation":[{"name":"Adana , Turkey"},{"name":"Scientific Research Institute of Heart Surgery and Organ Transplantation , Kyrgyzstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Bueno","sequence":"additional","affiliation":[{"name":"Centro Nacional de Investigaciones Cardiovasculares (CNIC) , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle C","family":"Van Gelder","sequence":"additional","affiliation":[{"name":"University Medical Center Groningen , University of Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Lettino","sequence":"additional","affiliation":[{"name":"Cardiovascular Department , Humanitas Research Hospital, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Marin","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednico , Universitario Virgen de la Arrixaca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Masip","sequence":"additional","affiliation":[{"name":"Cardiology Department , Hospital Sanitas CIMA, University of Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mueller","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute , University Hospital of Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sercan","family":"Okutucu","sequence":"additional","affiliation":[{"name":"Department of Cardiology , Memorial Ankara Hospital, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Poess","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\/Cardiology , Heart Center Leipzig-University Hospital, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana S","family":"Potpara","sequence":"additional","affiliation":[{"name":"School of Medicine , Belgrade University, Serbia"},{"name":"Cardiology Clinic , Clinical Center of Serbia, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Price","sequence":"additional","affiliation":[{"name":"Royal Brompton Hospital , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory YH","family":"Lip (Co-chair)","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science , University of Liverpool, UK"},{"name":"Aalborg Thrombosis Research Unit , Department of Clinical Medicine, Aalborg University, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,6,1]]},"reference":[{"key":"2026080914543884000_bibr1-2048872619894255","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080914543884000_bibr2-2048872619894255","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report","volume":"154","author":"Lip","year":"2018","journal-title":"Chest"},{"key":"2026080914543884000_bibr3-2048872619894255","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: Executive summary: A report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"2026080914543884000_bibr4-2048872619894255","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","article-title":"Atrial fibrillation: Epidemiology, pathophysiology, and clinical outcomes","volume":"120","author":"Staerk","year":"2017","journal-title":"Circ Res"},{"key":"2026080914543884000_bibr5-2048872619894255","first-page":"3250","article-title":"Atrial fibrillation in heart failure: What should we do?","volume":"36","author":"Kotecha","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080914543884000_bibr6-2048872619894255","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080914543884000_bibr7-2048872619894255","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/eurheartj\/ehv066","article-title":"Recommendations on pre-hospital and early hospital management of acute heart failure: A consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine\u2013short version","volume":"36","author":"Mebazaa","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080914543884000_bibr8-2048872619894255","first-page":"81","article-title":"European Society of Cardiology-Acute Cardiovascular Care Association Position paper on acute heart failure: A call for interdisciplinary care","volume":"6","author":"Mueller","year":"2017","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026080914543884000_bibr9-2048872619894255","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/eurjhf\/hfp085","article-title":"A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure","volume":"11","author":"Mamas","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026080914543884000_bibr10-2048872619894255","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.amjmed.2014.06.006","article-title":"New-onset atrial fibrillation predicts heart failure progression","volume":"127","author":"Aleong","year":"2014","journal-title":"Am J Med"},{"key":"2026080914543884000_bibr11-2048872619894255","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijcard.2017.06.033","article-title":"The interplay between atrial fibrillation and heart failure on long-term mortality and length of stay: Insights from the, United Kingdom ACALM registry","volume":"252","author":"Ziff","year":"2018","journal-title":"Int J Cardiol"},{"key":"2026080914543884000_bibr12-2048872619894255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2013.01.007","article-title":"Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation","volume":"165","author":"Bui","year":"2013","journal-title":"Am Heart J"},{"key":"2026080914543884000_bibr13-2048872619894255","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/CIRCHEARTFAILURE.111.965681","article-title":"Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: An analysis of Get With The Guidelines-Heart Failure","volume":"5","author":"Mountantonakis","year":"2012","journal-title":"Circ Heart Fail"},{"key":"2026080914543884000_bibr14-2048872619894255","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.amjcard.2018.09.036","article-title":"Meta-analysis of effects of digoxin on survival in patients with atrial fibrillation or heart failure: An update","volume":"123","author":"Vamos","year":"2019","journal-title":"Am J Cardiol"},{"key":"2026080914543884000_bibr15-2048872619894255","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ahj.2012.12.019","article-title":"Rate versus rhythm control for management of atrial fibrillation in clinical practice: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry","volume":"165","author":"Steinberg","year":"2013","journal-title":"Am Heart J"},{"key":"2026080914543884000_bibr16-2048872619894255","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/S0140-6736(14)61836-5","article-title":"Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: A retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)","volume":"385","author":"Washam","year":"2015","journal-title":"Lancet"},{"key":"2026080914543884000_bibr17-2048872619894255","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.hrthm.2014.06.007","article-title":"Digoxin in patients with permanent atrial fibrillation: Data from the RACE II study","volume":"11","author":"Mulder","year":"2014","journal-title":"Heart Rhythm"},{"key":"2026080914543884000_bibr18-2048872619894255","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.jacc.2015.04.045","article-title":"Digoxin use and subsequent outcomes among patients in a contemporary atrial fibrillation cohort","volume":"65","author":"Allen","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080914543884000_bibr19-2048872619894255","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/HJH.0000000000000559","article-title":"Digoxin use and risk of mortality in hypertensive patients with atrial fibrillation","volume":"33","author":"Okin","year":"2015","journal-title":"J Hypertens"},{"key":"2026080914543884000_bibr20-2048872619894255","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.hrthm.2015.05.016","article-title":"Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial","volume":"12","author":"Lee","year":"2015","journal-title":"Heart Rhythm"},{"key":"2026080914543884000_bibr21-2048872619894255","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/314041","article-title":"Digoxin use to control ventricular rate in patients with atrial fibrillation and heart failure is not associated with increased mortality","volume":"2015","author":"Chamaria","year":"2015","journal-title":"Cardiol Res Pract"},{"key":"2026080914543884000_bibr22-2048872619894255","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(16)31258-2","article-title":"Rate control in atrial fibrillation","volume":"388","author":"Van Gelder","year":"2016","journal-title":"Lancet"},{"key":"2026080914543884000_bibr23-2048872619894255","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/emj.2010.109702","article-title":"Cardioversion of acute atrial fibrillation in the emergency department: A prospective randomised trial","volume":"29","author":"Bellone","year":"2012","journal-title":"Emerg Med J"},{"key":"2026080914543884000_bibr24-2048872619894255","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"2026080914543884000_bibr25-2048872619894255","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","article-title":"Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: An individual-patient data meta-analysis","volume":"384","author":"Kotecha","year":"2014","journal-title":"Lancet"},{"key":"2026080914543884000_bibr26-2048872619894255","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2011.11.063","article-title":"Eplerenone and atrial fibrillation in mild systolic heart failure: Results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study","volume":"59","author":"Swedberg","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080914543884000_bibr27-2048872619894255","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/europace\/eux163","article-title":"European Heart Rhythm Association (EHRA)\/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)","volume":"19","author":"Gorenek","year":"2017","journal-title":"Europace"},{"key":"2026080914543884000_bibr28-2048872619894255","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.hrthm.2012.09.007","article-title":"Temporary left ventricular stimulation in patients with refractory cardiogenic shock and asynchronous left ventricular contraction: A safety and feasibility study","volume":"10","author":"Eitel","year":"2013","journal-title":"Heart Rhythm"},{"key":"2026080914543884000_bibr29-2048872619894255","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"2026080914543884000_bibr30-2048872619894255","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.hrthm.2017.12.001","article-title":"Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction","volume":"15","author":"Black-Maier","year":"2018","journal-title":"Heart Rhythm"},{"key":"2026080914543884000_bibr31-2048872619894255","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/europace\/euv440","article-title":"Catheter ablation of atrial fibrillation in patients with heart failure: Impact of maintaining sinus rhythm on heart failure status and long-term rates of stroke and death","volume":"18","author":"Ullah","year":"2016","journal-title":"Europace"},{"key":"2026080914543884000_bibr32-2048872619894255","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1160\/TH16-11-0876","article-title":"Stroke prevention in atrial fibrillation: Past, present and future","volume":"117","author":"Lip","year":"2017","journal-title":"Thromb Haemost"},{"key":"2026080914543884000_bibr33-2048872619894255","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.clinthera.2014.07.015","article-title":"The impact of heart failure and left ventricular dysfunction in predicting stroke, thromboembolism, and mortality in atrial fibrillation patients: A systematic review","volume":"36","author":"Agarwal","year":"2014","journal-title":"Clin Ther"},{"key":"2026080914543884000_bibr34-2048872619894255","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ijcard.2015.10.220","article-title":"Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes","volume":"203","author":"Kotecha","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026080914543884000_bibr35-2048872619894255","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/jth.13386","article-title":"Bleeding risk assessment in atrial fibrillation: Observations on the use and misuse of bleeding risk scores","volume":"14","author":"Lip","year":"2016","journal-title":"J Thromb Haemost"},{"key":"2026080914543884000_bibr36-2048872619894255","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1160\/TH15-07-0565","article-title":"Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy","volume":"114","author":"Lip","year":"2015","journal-title":"Thromb Haemost"},{"key":"2026080914543884000_bibr37-2048872619894255","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1538-7836.2010.03756.x","article-title":"Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users","volume":"8","author":"Witt","year":"2010","journal-title":"J Thromb Haemost"},{"key":"2026080914543884000_bibr38-2048872619894255","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080914543884000_bibr39-2048872619894255","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080914543884000_bibr40-2048872619894255","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"2026080914543884000_bibr41-2048872619894255","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080914543884000_bibr42-2048872619894255","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/ejhf.343","article-title":"Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: A systemic review and meta-analysis of randomized trials","volume":"17","author":"Xiong","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026080914543884000_bibr43-2048872619894255","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/europace\/eux301","article-title":"Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: A report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) long-term general registry","volume":"20","author":"Boriani","year":"2018","journal-title":"Europace"},{"key":"2026080914543884000_bibr44-2048872619894255","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2017.10.085","article-title":"Relationship of aging and incident comorbidities to stroke risk in patients with atrial fibrillation","volume":"71","author":"Chao","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026080914543884000_bibr45-2048872619894255","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","article-title":"The ABC pathway: An integrated approach to improve AF management","volume":"14","author":"Lip","year":"2017","journal-title":"Nat Rev Cardiol"}],"container-title":["European Heart Journal: Acute Cardiovascular Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2048872619894255","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2048872619894255","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/ehjacc\/article-pdf\/9\/4\/348\/34227546\/ehjacc0348.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjacc\/article-pdf\/9\/4\/348\/34227546\/ehjacc0348.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T18:54:48Z","timestamp":1786301688000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjacc\/article\/9\/4\/348\/5950241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,6,1]]},"published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1177\/2048872619894255","relation":{},"ISSN":["2048-8734","2048-8726"],"issn-type":[{"value":"2048-8734","type":"electronic"},{"value":"2048-8726","type":"print"}],"subject":[],"published-other":{"date-parts":[[2020,6,1]]},"published":{"date-parts":[[2020,6,1]]}}}